Type 2 Diabetes
Showing NaN - NaN of 55
Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo-matching dapagliflozin)
Completed
- Type 2 Diabetes
- Dapagliflozin
- Placebo-matching dapagliflozin
-
Birmingham, Alabama
- +328 more
Dec 2, 2016
Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin)
Completed
- Type 2 Diabetes
- Dapagliflozin
- Placebo matching Dapagliflozin
-
Birmingham, Alabama
- +297 more
Nov 10, 2016
Type 1 Diabetes, Type 2 Diabetes Trial in United States (Enlite 3, Guardian Mobile App, 640G Insulin Pump)
Completed
- Type 1 Diabetes
- Type 2 Diabetes
- Enlite 3
- +2 more
-
Escondido, California
- +5 more
Oct 31, 2016
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)
Terminated
- Type 2 Diabetes
- Cardiovascular Disease
- TAK-875
- TAK-875 Placebo
-
Birmingham, Alabama
- +587 more
Oct 15, 2015
Type 2 Diabetes Trial in United States (ITCA 650, ITCA )
Completed
- Type 2 Diabetes
- ITCA 650
- ITCA placebo
-
Birmingham, Alabama
- +121 more
Jul 28, 2015
Type 2 Diabetes, Hypogonadism Trial in United States (Androgel (testosterone gel))
Completed
- Type 2 Diabetes
- Hypogonadism
- Androgel (testosterone gel)
-
Birmingham, Alabama
- +69 more
Jan 19, 2015
Type 2 Diabetes, Hypertension Trial in Atlanta (Rosiglitazone, Normal saline 0.9%, Intralipid 20%)
Completed
- Type 2 Diabetes
- Hypertension
- Rosiglitazone
- +2 more
-
Atlanta, GeorgiaGrady Memorial Hospital
Dec 18, 2014
A 2-Month Safety Follow-Up Trial
Completed
- Type 1 Diabetes
- Type 2 Diabetes
- Technosphere Insulin Inhalation Powder
- Comparator
-
Birmingham, Alabama
- +149 more
Dec 1, 2014
Type 2 Diabetes Trial in India, United States (Tagatose, Sugar Substitute Splenda)
Type 2 Diabetes Trial in United States (Technosphere® Insulin Inhalation Powder, Insulin Aspart, Insulin Glargine)
Terminated
- Type 2 Diabetes
- Technosphere® Insulin Inhalation Powder
- +2 more
-
Mobile, Alabama
- +28 more
Oct 21, 2014
Type 2 Diabetes Trial in Worldwide (Technosphere® Insulin, Technosphere Powder)
Completed
- Type 2 Diabetes
- Technosphere® Insulin
- Technosphere Powder
-
Anaheim, California
- +75 more
Oct 9, 2014
Type 2 Diabetes Trial in United States ("GLIPULIN:" [insulin glargine, metformin, exenatide (GLP-1-agonist)], Insulin glargine,
Completed
- Type 2 Diabetes
- "GLIPULIN:" [insulin glargine, metformin, exenatide (GLP-1-agonist)]
- Insulin glargine, metformin, prandial insulin
-
San Diego, California
- +11 more
Sep 16, 2014
Type 2 Diabetes Trial in Atlanta, Chicago (Detemir + aspart insulin before meals, NPH insulin + regular insulin)
Completed
- Type 2 Diabetes
- Detemir + aspart insulin before meals
- NPH insulin + regular insulin
-
Atlanta, Georgia
- +1 more
Jun 6, 2014
Abbott Sensor Based Interstitial Glucose Monitoring System
Completed
- Type 1 Diabetes
- Type 2 Diabetes
- No treatment
-
Escondido, California
- +3 more
May 22, 2014
Type 2 Diabetes, Inpatient Hyperglycemia Trial in Atlanta (Insulin glargine, Regular insulin, Insulin glulisine)
Completed
- Type 2 Diabetes
- Inpatient Hyperglycemia
- Insulin glargine
- +2 more
-
Atlanta, Georgia
- +1 more
Feb 7, 2014
Type 2 Diabetes Trial in United States (Placebo for Nasulin, Nasulin)
Type 2 Diabetes, Chronic Kidney Disease Trial in United States (Zemplar, Placebo)
Unknown status
- Type 2 Diabetes
- Chronic Kidney Disease
- Zemplar
- Placebo
-
Atlanta, Georgia
- +3 more
Feb 12, 2013
Type 2 Diabetes Trial in Mexico, Peru, United States (Colesevelam HCl)
Completed
- Type 2 Diabetes
- Colesevelam hydrochloride
-
Birmingham, Alabama
- +46 more
Jan 16, 2012
Type 2 Diabetes Trial in Mexico, Peru, United States (Colesevelam HCl)
Completed
- Type 2 Diabetes
- Colesevelam hydrochloride
-
Jonesboro, Arkansas
- +47 more
Jan 16, 2012
Type 2 Diabetes, Type 2 Diabetes Trial in Worldwide (dutogliptin)
Terminated
- Type 2 Diabetes Mellitus
- Type 2 Diabetes
-
Norwalk, California
- +67 more
Aug 10, 2010